TRANScribing: Clinical considerations for safe and inclusive prescribing for transgender and non-binary patients
BOPA is delighted to announce the publication of TRANScribing: Clinical considerations for safe and inclusive prescribing for transgender and non-binary patients in collaboration with OUTpatients.
It is estimated that one in a hundred patients may be transgender, therefore it is important for healthcare professionals to be able to provide inclusive care with safe and effective prescribing.
BOPA and OUTpatients came together to develop this world first resource that guides and supports healthcare professionals while caring for their transgender patients.
The document is available via here.
